Holdings

iShares Neuroscience and Healthcare ETF

As of Jul 31, 2026, iShares Neuroscience and Healthcare ETF reported 66 positions worth US$5.24M. Largest: Dianthus Therapeutics, Inc., Xenon Pharmaceuticals Inc. and Praxis Precision Medicines, Inc. What it bought and sold, with each filing.

Holdings

Part of
BlackRock
Positions
66
Value as reported
US$5.24M
Holdings as of
Jul 31, 2026
Last filed
Sep 23, 2026
CompanySharesValue as reported% of portfolioChangeAs of
Dianthus Therapeutics, Inc.
NASDAQ:DNTH
2,739US$293K5.3%+741Jul 31, 2026
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
4,264US$267K4.9%−155Jul 31, 2026
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
868US$267K4.9%+274Jul 31, 2026
ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
9,949US$257K4.7%+1,621Jul 31, 2026
Arrowhead Pharmaceuticals, Inc.
NASDAQ:ARWR
3,016US$255K4.7%−87Jul 31, 2026
Alkermes plc
NASDAQ:ALKS
5,153US$252K4.6%−1,293Jul 31, 2026
Scholar Rock Holding Corporation
NASDAQ:SRRK
4,979US$235K4.3%+904Jul 31, 2026
Biogen Inc.
NASDAQ:BIIB
1,129US$229K4.2%+125Jul 31, 2026
Neurocrine Biosciences, Inc.
NASDAQ:NBIX
1,345US$224K4.1%−103Jul 31, 2026
PTC Therapeutics, Inc.
NASDAQ:PTCT
3,109US$211K3.9%+171Jul 31, 2026
Axsome Therapeutics, Inc.
NASDAQ:AXSM
949US$207K3.8%−195Jul 31, 2026
Denali Therapeutics Inc.
NASDAQ:DNLI
8,750US$201K3.7%+950Jul 31, 2026
Dyne Therapeutics, Inc.
NASDAQ:DYN
7,764US$195K3.6%+798Jul 31, 2026
Edgewise Therapeutics, Inc.
NASDAQ:EWTX
4,615US$177K3.2%+383Jul 31, 2026
Supernus Pharmaceuticals, Inc.
NASDAQ:SUPN
3,202US$143K2.6%+202Jul 31, 2026
Axogen, Inc.
NASDAQ:AXGN
3,041US$128K2.3%+241Jul 31, 2026
SK Biopharmaceuticals Co., Ltd.
KRX:326030
2,295US$126K2.3%+748Jul 31, 2026
H. Lundbeck A/S Class A
OMXCOP:HLUN_A
15,754US$101K1.8%+992Jul 31, 2026
Biohaven Ltd.
NYSE:BHVN
7,377US$99,5901.8%+361Jul 31, 2026
Sarepta Therapeutics, Inc.
NASDAQ:SRPT
5,954US$88,4761.6%+474Jul 31, 2026
BioArctic AB Class B
OMXSTO:BIOA_B
2,506US$85,5631.6%+480Jul 31, 2026
Taysha Gene Therapies, Inc.
NASDAQ:TSHA
13,999US$82,0341.5%+1,630Jul 31, 2026
Neuren Pharmaceuticals Limited
ASX:NEU
6,435US$81,1131.5%+419Jul 31, 2026
Idorsia Ltd.
SIX:IDIA
10,423US$78,9651.4%+858Jul 31, 2026
Rapport Therapeutics, Inc.
NASDAQ:RAPP
1,673US$68,5601.2%+63Jul 31, 2026
Integra LifeSciences Holdings Corporation
NASDAQ:IART
3,915US$65,1851.2%+240Jul 31, 2026
Alto Neuroscience, Inc.
NYSE:ANRO
1,846US$49,9710.91%+275Jul 31, 2026
LB Pharmaceuticals Inc
NASDAQ:LBRX
1,221US$48,9380.89%+185Jul 31, 2026
Dynavox Group AB
OMXSTO:DYVOX
5,818US$43,8860.80%+367Jul 31, 2026
Annexon, Inc.
NASDAQ:ANNX
8,380US$42,6960.78%+1,332Jul 31, 2026
MedinCell SA
EURONEXT:MEDCL
1,372US$41,2560.75%+217Jul 31, 2026
Solid Biosciences Inc.
NASDAQ:SLDB
4,599US$37,0680.68%+1,297Jul 31, 2026
Bright Minds Biosciences Inc.
CSE:DRUG
445US$32,6010.59%−94Jul 31, 2026
Relmada Therapeutics, Inc.
NASDAQ:RLMD
5,416US$28,7590.52%+2,082Jul 31, 2026
Design Therapeutics, Inc.
NASDAQ:DSGN
2,215US$26,9790.49%+471Jul 31, 2026
Regenxbio Inc.
NASDAQ:RGNX
2,749US$26,6380.49%+217Jul 31, 2026
Oncolys BioPharma, Inc.
TSE:4588
1,600US$26,3070.48%+200Jul 31, 2026
CeriBell, Inc.
NASDAQ:CBLL
1,447US$25,5970.47%+110Jul 31, 2026
Neurogene Inc.
NASDAQ:NGNE
740US$24,3390.44%+62Jul 31, 2026
ClearPoint Neuro Inc.
NASDAQ:CLPT
1,572US$23,4860.43%+154Jul 31, 2026
Benitec Biopharma Inc.
NASDAQ:BNTC
1,981US$23,1980.42%+183Jul 31, 2026
Prothena Corporation plc
NASDAQ:PRTA
2,759US$22,4030.41%+367Jul 31, 2026
Ovid Therapeutics Inc.
NASDAQ:OVID
9,777US$21,7050.40%+3,413Jul 31, 2026
MicroPort NeuroScientific Corporation
HKEX:2172
19,000US$21,6570.39%+1,000Jul 31, 2026
NeuroPace, Inc.
NASDAQ:NPCE
1,543US$19,8890.36%+145Jul 31, 2026
SanBio Co., Ltd.
TSE:4592
3,400US$19,5550.36%+200Jul 31, 2026
Zylox-Tonbridge Medical Technology Co., Ltd. Class H
HKEX:2190
8,000US$19,4170.35%−1,000Jul 31, 2026
Vanda Pharmaceuticals Inc.
NASDAQ:VNDA
3,342US$17,0440.31%+346Jul 31, 2026
Newron Pharmaceuticals S.p.A.
SIX:NWRN
1,060US$15,3620.28%+69Jul 31, 2026
Anavex Life Sciences Corp.
NASDAQ:AVXL
5,343US$14,6930.27%+400Jul 31, 2026
Peijia Medical Ltd.
HKEX:9996
28,000US$14,3130.26%+2,000Jul 31, 2026
Santhera Pharmaceuticals Holding AG
SIX:SANN
771US$13,5120.25%+115Jul 31, 2026
Inhibikase Therapeutics, Inc.
NASDAQ:IKT
5,679US$12,3800.23%+599Jul 31, 2026
Capricor Therapeutics, Inc.
NASDAQ:CAPR
3,077US$11,8460.22%+384Jul 31, 2026
Larimar Therapeutics, Inc.
NASDAQ:LRMR
3,008US$11,4910.21%+727Jul 31, 2026
Tonix Pharmaceuticals Holding Corp.
NASDAQ:TNXP
953US$9,5400.17%+265Jul 31, 2026
Voyager Therapeutics, Inc.
NASDAQ:VYGR
3,080US$9,3320.17%+566Jul 31, 2026
Entrada Therapeutics, Inc.
NASDAQ:TRDA
1,328US$9,0170.16%+150Jul 31, 2026
AC Immune SA
NASDAQ:ACIU
3,783US$8,2850.15%+433Jul 31, 2026
Acumen Pharmaceuticals, Inc.
NASDAQ:ABOS
3,768US$8,1010.15%+1,213Jul 31, 2026
Alector, Inc.
NASDAQ:ALEC
4,762US$7,1910.13%+654Jul 31, 2026
Neumora Therapeutics, Inc.
NASDAQ:NMRA
4,388US$7,0650.13%+1,328Jul 31, 2026
Myung In Pharm Co., Ltd.
KRX:317450
212US$6,2410.11%+1Jul 31, 2026
PepGen Inc.
NASDAQ:PEPG
3,476US$6,1180.11%+120Jul 31, 2026
MapLight Therapeutics, Inc.
NASDAQ:MPLT
445US$5,7940.11%−232Jul 31, 2026
Cognition Therapeutics, Inc.
NASDAQ:CGTX
4,543US$4,0410.07%+200Jul 31, 2026